SYT13 and amyotrophic lateral sclerosis: In line with this evidence, the phosphorylated form of SYT13 (serine 104) was detected only in the MN samples obtained from healthy controls and not from heterogeneous ALS patients with C9orf72, FUS, TBK1 and TARDBP mutations (Fig. 1B) [13].